TBC1D2B Antibodies

Santa Cruz Biotechnology offers a broad range of TBC1D2B monoclonal antibodies for research applications. TBC1D2B monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D2B is a member of the TBC (Tre-2/Bub2/CDC16) domain family, which plays a crucial role in regulating cellular processes such as vesicle trafficking and signal transduction. TBC1D2B has demonstrated significance in insulin signaling and glucose homeostasis, making it an important target for metabolic disorder research. Understanding TBC1D2B functionality can reveal key mechanisms underlying conditions like obesity and diabetes. Researchers can explore TBC1D2B's role in various cellular pathways and its impact on metabolic regulation. Advanced research techniques combined with high-quality monoclonal antibodies enable detailed investigation of TBC1D2B's molecular interactions and functions. Santa Cruz Biotechnology monoclonal antibodies for TBC1D2B support researchers worldwide in advancing scientific knowledge and developing potential therapeutic strategies for metabolic diseases.